Neutrophil-lymphocyte ratio predicts the prognosis of patients with hepatocellular carcinoma after liver transplantation

Table 3 Multivariate analysis of the effects of clinicopathological factors on the disease-free survival of patients with hepatocellular carcinoma who underwent liver transplantationpatients with hepatocellular carcinoma who underwent liver transplantation

Variable	χ2	P value	HR	95%CI
Age, yr (≥ 60/< 60)	2.731	0.098	0.561	0.283-1.113
AFP, g/L (< 400/≥ 400)	0.397	0.529	1.128	0.776-1.640
NLR (< 4/≥ 4)	9.260	0.0021	1.758	1.222-2.527
Tumor No. ( ≤ 3/> 3)	1.450	0.229	1.301	0.848-1.997
Largest tumor size, > 5 cm	1.761	0.185	1.378	0.858-2.214
Total tumor size, > 9 cm	16.939	< 0.0011	2.725	1.691-3.393
Macro-vascular invasion (Y/N)	11.168	< 0.0011	2.013	1.336-3.035
Micro-vascular invasion (Y/N)	3.085	0.071	1.597	1.001-2.546

¹Significant P value. NLR: Neutrophil-lymphocyte ratios; AFP: α-fetoprotein.